Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
30M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
1.97M
-
Shares change
-
+389K
-
Total reported value, excl. options
-
$2.08M
-
Value change
-
+$330K
-
Put/Call ratio
-
0.47
-
Number of buys
-
8
-
Number of sells
-
-16
-
Price
-
$1.06
Significant Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q2 2024
39 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share as of Q2 2024.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.97M shares
of 30M outstanding shares and own 6.58% of the company stock.
Largest 10 shareholders include Kent Lake Capital LLC (696K shares), VANGUARD GROUP INC (594K shares), Cresset Asset Management, LLC (300K shares), GEODE CAPITAL MANAGEMENT, LLC (136K shares), RENAISSANCE TECHNOLOGIES LLC (75.5K shares), BlackRock Inc. (54.7K shares), Compagnie Lombard Odier SCmA (25K shares), NORTHERN TRUST CORP (24.9K shares), STATE STREET CORP (23.2K shares), and XTX Topco Ltd (21.4K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.